THE Federal Government's introduction of the proposed Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024 yesterday into Parliament aims to reform the vaping landscape in Australia.
In response to the introduction of the bill, provider of Australian standard therapeutic nicotine vape products (NVPs), from the fields Pharmaceutical CEO Wilhelm David expressed optimism about its potential impact on the Australian vaping industry.
"Introduced federal legislation can tackle our illicit black vape market and underpin Australian quality standard therapeutic vape product," said David, highlighting the importance of regulating the market to ensure consumer safety and product quality.
The Federal Health Minister, Mark Butler, presented the bill, emphasising its proactive approach to addressing the challenges posed by vaping.
According to David, the legislation aims to promote the sustainability of the medical prescription and pharmacy distribution model for NVPs, while also targeting a reduction in smoking rates.
"The legitimate therapeutic vape industry in Australia has been unnecessarily squeezed by an out-of-control illegal black market for vapes," he commented.
David urged federal MPs to support the bill, emphasising the importance of public health outcomes and the need for effective communication between medical practitioners, pharmacies, and patients regarding smoking cessation options.
"We argue well-funded, but effective, public information campaigns are vital across both Federal and State jurisdictions, from supply quality, regulated therapeutic product to genuine users and improve public health outcomes," he concluded. JG
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Mar 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Mar 24
